key: cord-0735003-9q1zat8k authors: Cubas Atienzar, A. I.; Kontogianni, K.; Edwards, T.; Wooding, D.; Buist, K.; Thompson, C. R.; Williams, C. T.; Baldwin, L.; Patterson, I.; Hughes, G.; Escadafal, C.; Sacks, J.; Adams, E. R. title: Limit of detection in different matrices of nineteen commercially available rapid antigen tests for the detection of SARS-CoV-2 date: 2021-03-22 journal: nan DOI: 10.1101/2021.03.19.21253950 sha: ca145ff8e5299ca0ed9c334ad3cd1ed44f4beff1 doc_id: 735003 cord_uid: 9q1zat8k In the context of the coronavirus disease 2019 (COVID-19) pandemic there has been an increase of the use of antigen-detection rapid diagnostic tests (Ag-RDT). The performance of Ag-RDT vary greatly between manufacturers and evaluating their analytical limit of detection (LOD) has become high priority. Here we describe a manufacturer-independent evaluation of the LOD of 19 marketed Ag-RDT using live SARS-CoV-2 spiked in different matrices: direct culture supernatant, a dry swab, and a swab in Amies. Additionally, the LOD using dry swab was investigated after 7-days storage at -80C of the SARS-CoV-2 serial dilutions. An LOD of {approx} 5.0 x 10^2 pfu/ml (1.0 x 10^6 genome copies/ml) in culture media is defined as acceptable by the World Health Organization. Fourteen of nineteen Ag-RDTs (ActiveXpress, Espline, Excalibur, Innova, Joysbio, Mologic, NowCheck, Orient, PanBio, RespiStrip, Roche, Standard-F, Standard-Q and Sure-Status) exceeded this performance criteria using direct culture supernatant applied to the Ag-RDT. Six Ag-RDT were not compatible with Amies media and a decreased sensitivity of 2 to 20-fold was observed for eleven tests on the stored dilutions at -80C for 7 days. Here, we provide analytical sensitivity data to guide appropriate test and sample type selection for use and for future Ag-RDT evaluations. Ag-RDTs are faster, cheaper and can be available at the point-of-care (POC), which is 49 especially important for implementation in community and low-resource settings, where limited 50 laboratories and trained staff are available, and there may be suboptimal cold chain capacity to 51 ensure appropriate conditions for more complex testing 7-9 . Furthermore, their use could also 52 enable rapid isolation of cases and their contacts. 53 Ag-RDTs are less sensitive than RT-PCR, but clinical evaluation data is emerging that 54 demonstrates Ag-RDTs are accurate at detecting the vast majority of individuals with a high-55 viral load (cycle threshold (Ct) on RT-PCR ≤ 25.0 or >10 6 genomic virus copies/ml) 7,10-16 . In 56 addition, in outbreak scenarios, a diagnostic test with lower sensitivity but a fast result enables 57 quick interventions such as self-isolation and isolating contacts of cases 17 . Implementation of 58 Ag-RDTs into testing algorithms would allow rapid detection and isolation of new cases and 59 thereby support the test, trace and isolate strategy, aiming to stop transmission chains and 60 reduce the impact of COVID-19. 61 Ag-RDTs have been recently used for screening asymptomatic people in high prevalence areas 62 and frontline workers to quickly identify persons with a SARS-CoV-2 infection to adapt infection 63 prevention and control measures, thus preventing transmission in the community 18-20 . A mass 64 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. easier. Therefore, we performed this experiment to understand whether LOD is impacted 128 following sample storage. The LOD of each of the tests using SARS-CoV-2 serial dilutions after 129 7 days storage at -80°C and one freeze-thaw cycle is shown in Table 2 . 130 The LOD for 6 tests (ActiveXpress, Bioeasy, iChroma, NowCheck, RespiStrip and Wondfo) was 131 equivalent using stored, frozen viral dilutions compared to fresh preparations. Three tests 132 showed increased sensitivity (lower LOD by 2 to 5-fold) (Joysbio, PanBio and Standard-Q), and 133 eleven showed poorer performance with a higher LOD of 2-fold (Biocredit, Espline, Roche and 134 Sure-Status), 4-5 (Excalibur, Mologic and Orient), ten (Innova) and twenty (Genedia and 135 Standard-F). 136 Here, we present the analytical performance of nineteen antigen rapid tests, which are currently 138 on the market and in use in multiple countries. Analytical LODs are a useful proxy of clinical 139 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. sensitivity, and the most standardized way to evaluate multiple antigen tests head-to-head, as 140 each test requires a separate swab from patients. An approximate LOD of ≤ 5.0 x 10 2 pfu/ml (≈ 141 1.0 x 10 6 copies/ml) calculated using direct culture supernatant, has been proposed as the and none of the tests met that LOD target when using swabs in Amies, like due to the dilution 151 factor with the addition of 1 ml Amies buffer as well as potential chemical interactions between 152 the media and the kit-specific buffers. 153 The more absorbent swabs will absorb more viral material, and so we investigated if the volume 154 retained by the swab had any bearing on the LOD of each test when compared with the LOD 155 achieved with direct culture supernatant. We took into account the volume recovered from the 156 swab and the volume of proprietary buffer provided, but no correlation was found, this suggests 157 that other factors may reduce the sensitivity when using swabs such as differences in the 158 formulation of the proprietary buffers. A reduction in sensitivity using clinical samples may be 159 observed compared to swabs in viral culture, as clinical samples are more viscous than culture 160 media, potentially resulting in less viral material being absorbed onto the swab. The efficiency of 161 the recovery is also likely to be increased by the centrifugation method used in our protocol. 162 We also evaluated the LOD and compatibility of the Ag-RDTs using a swab placed in Amies 163 media, as these are routinely used to collect upper-respiratory samples in SARS-CoV-2 164 suspected individuals for diagnosis using RT-PCR 27,28 . If the same swab proves to be suitable 165 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. and we demonstrated here that this 'off-label' sample preparation should be used with caution: 170 six tests had false positive results (Espline, Excalibur, Joysbio, Sure-Status and Orient) and 171 sensitivity was also reduced due to the additional volume of Amies. 172 The effect of storage at -80°C and one freeze-thaw cycle was evaluated, with eleven Ag-RDTs 173 showing a loss of sensitivity by up to twenty-fold. A small decrease in sensitivity has been 174 reported in in SARS-CoV-2 RT-PCR testing (<1 RT-PCR cycle threshold) after one and two 175 freeze-thaw cycles 29 but there are no studies so far that have reported the effect of freeze-thaw 176 on antigen detection. Results here highlight that the use of frozen material with Ag-RDTs should 177 be performed with caution. The fact that three tests showed two-to-five-fold better sensitivity 178 after an additional freeze thaw-cycle could not be explained in here, a further investigation is 179 required with a larger sample size to rule out whether this phenomenon was within the margin of 180 error of the experiment. 181 Three out of nineteen Ag-RDTs (Bioeasy, iChroma and Standard-F) rely on detection of a 182 fluorescent signal using a reader. Though this may enable quantitative detection and potentially 183 more consistent result interpretation, we did not find any improved sensitivity for this test format. 184 Furthermore, Ag-RDTs that rely on a device may limit testing throughput if only one test can be 185 read at a time. The reader also presents additional costs, as well as potential technical and 186 maintenance issues which can be a barrier to implementation. 187 This analytical study has some limitations, as only a single isolate 188 (REMRQ0001/Human/2020/Liverpool) was used to assess the LODs but our results are 189 consistent with other recently-published analyses 30,31 . To the authors knowledge, all 19 tests 190 evaluated here detect the nucleoprotein, presumably chosen for abundance and relative low 191 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. There is a growing number of studies suggesting that although antigen detection is less 194 analytically sensitive than nucleic acid amplification techniques, it may strongly correlate with 195 culturable virus, which may be a proxy for transmissibility. Hence Ag-RDTs could be informative 196 for test, trace, isolate processes for the most infectious individuals 10-15 . Viral loads have been 197 estimated to range from 10 8 to 10 11 gcn/ml in the most infectious patients [34] [35] [36] In conclusion, the most sensitive tests with an LOD ≤ 5.0 x 10 2 pfu/ml (≈ 1.2 x10 6 gcn/ml) on dry 203 swabs and direct culture supernatant were Espline, Mologic, Sure-Status and Roche and the 204 least sensitive on all matrices were Biocredit, iChroma, Standard-F and Genedia. The 205 differences of LODs found here between tests and/or matrices ranged between 2-3 logs (i.e. 206 100-1,000 fold). Some tests showed impaired performance when using freeze-thaw material 207 and/or Amies media. These findings highlight the importance of understanding assay specific 208 performances and the need to select the appropriate sample matrix and the right test for each 209 intended use, particularly for laboratories and evaluation programs that seek a rapid validation 210 of Ag-RDT using frozen stored samples and 'off-label' specimen preparations. The LODs 211 obtained in this comprehensive assessment of analytical sensitivity are consistent with rapidly 212 emerging clinical performance data 9,11,37 demonstrating the high clinical accuracy of Ag-RDTs 213 for rapid detection of individuals with high viral loads, which can be very impactful for initiation of 214 isolation and tracing measures. 215 216 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Nineteen Ag-RDT based on lateral flow principle were evaluated in this study (Table 1) Companies had no involvement in the design or reporting of the study. 240 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The SARS-CoV-2 isolate REMRQ0001/Human/2020/Liverpool was propagated in Vero E6 cells 242 (C1008; African green monkey kidney cells), maintained in DMEM with 2% fetal bovine serum 243 (FBS) and 0.05 mg/ml gentamycin. Ten-fold serial dilutions of SARS-CoV-2 stock were made 244 starting from 1.0 x 10 6 pfu/ml to 1.0 x 10 2 pfu/ml using culture media as a diluent (DMEM with 245 2% FBS % and 0.05 mg/ml gentamycin). Two-fold dilutions were made below the ten-fold LOD 246 dilution to refine the LOD. For quantification, viral RNA was extracted using QIAmp Viral RNA 247 mini kit (Qiagen, Germany) according to the manufacturer's instructions. The genome copies/ml 248 (gcn/ml) were calculated using the COVID-19 Genesig RT-qPCR kit (PrimerDesign, UK). RT-249 qPCR testing was carried out using the Rotor-Gene Q (Qiagen, Germany), with a ten-fold serial 250 dilution of using quantified specific in vitro-transcribed RNA 38 . A total of five replicates were 251 tested for each standard curve point and extracted RNA from each culture dilution was tested in 252 triplicate, and the gcn/ml was calculated from the mean Ct value of these replicates. 253 Three types of sample matrices were tested 1) direct viral culture supernatant, 2) spiked dry 255 swabs and 3) spiked wet swabs in Amies media. 256 For the direct viral culture matrix, a specific volume of the serial dilutions was added directly to 257 the extraction buffers at a 1:10 ratio except for Respi-Strip which was added at 1:1 ratio with the 258 extraction buffer following the IFU. 259 For dry swab testing, the proprietary nasopharyngeal (NP) or nasal (N) swabs included in each 260 individual kit was used except for Respi-Strip, which does not include swabs, and the 261 recommended Eswab (Copan, Italy) was used instead. To prepare the dry swab matrix, the 262 swab was soaked in 1 ml of the virus culture dilution series for 6-8 seconds, followed by 263 immersion in the prescribed amount of proprietary reaction buffer solution. 264 For the preparation of spiked wet swabs, Eswab in Amies media (Copan, Italy) was used across 265 all tests. The swab was first immersed in the serial viral dilutions for 6-8 seconds, then placed 266 into the Amies media to mimic the sample collection stage. Ag-RDTs were evaluated by then 267 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. For all Ag-RDTs and matrices, the sample volumes applied, and procedures were performed as 270 specified in the test specific IFUs. 271 The LOD was defined as the lowest dilution at which all three replicates were positive. Every 272 dilution was tested in triplicate and non-spiked culture media and Amies were used as negative 273 controls. Results were interpreted by two operators, each blinded to the result of the other. If a 274 discrepant result was obtained, a third operator read any discrepant tests for a 2/3 result. 275 We investigated the effect of the absorbance of the proprietary swabs provided with the Ag-RDT 277 kit in the LOD using dry swab, i.e. if a less absorbent swab resulted in a poorer LOD on dry 278 swab compared with direct culture supernatant. To compare the effectiveness of each NP and N 279 swab to recover sample, the amount of liquid absorbed by the swabs was measured. Five 280 replicates of each swab brand were immersed in culture media for 6-8 seconds, then taped on 281 the inside of a 50ml centrifuge tube. These were then centrifuged for 5 minutes at 1000g and 282 the amount of liquid released was measured using a micropipette. The dilution factor of each 283 test type was calculated taking into account the volume recovered by swab and volume of 284 proprietary buffer in which the swab was immersed. 285 The degree of correlation of LOD by swabs with the volume recovered by swab type, volume of 286 proprietary buffer and dilution factor were investigated by Spearman's correlation coefficient rho 287 (ρ). Statistical significance was set at P <0.05. 288 LOD after 7 days at -80° C and one freeze-thaw cycle 289 After performing the LOD experiments, the viral culture dilutions were stored at -80 °C for 7 290 days and then the LOD experiments were performed again using the dry NP and N swabs. This 291 would help to assess the use of stored clinical samples could be used to facilitate evaluation of 292 Ag-RDTs. 293 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 22, 2021. ; https://doi.org/10.1101/2021.03.19.21253950 doi: medRxiv preprint 13 Data availability. All data generated during this study is presented in an analysed format in this 294 manuscript. Raw datasets are available from the corresponding author on reasonable request. 295 Authors' contributions: The study and design of the study was conceived by AICA, JS and 296 ERA. Laboratory testing was performed by AICA, KK, TE, CW, DW, KB, CT. Data analysis and 297 interpretation were conducted by AICA. The initial manuscript was prepared by AICA. All authors 298 edited and approved the final manuscript. 299 Sources of funding: The study was supported by FIND. The funders of the study had no 300 role in data collection and data analysis. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Diagnostic detection of 2019-309 nCoV by real-time RT-PCR RNA Extraction Kits for COVID-19 Tests Are in Short Supply in US Severe shortages of swabs and other supplies 315 hamper coronavirus testing -CNN Impact of delays on effectiveness of contact tracing 323 strategies for COVID-19: a modelling study Antigen-detection in the diagnosis of SARS CoV-2 infection using rapid immunoassays Rapid development of COVID-19 rapid diagnostics for low 328 resource settings: accelerating delivery through transparency, responsiveness, 329 and open collaboration Evaluation of the accuracy, ease of use and limit of detection of 331 novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2 Rapid antigen testing and non-infectious 334 shedding of SARS-Cov2 Clinical evaluation of the Roche/SD Biosensor rapid antigen test 337 with symptomatic, non-hospitalized patients in a municipal health service drive-338 through testing site Rethinking Covid-19 Test Sensitivity -340 A Strategy for Containment Antigen-based testing but not real-time PCR correlates with 344 SARS-CoV-2 virus culture Duration of infectiousness and correlation with RT-PCR 346 cycle threshold values in cases of COVID-19 Laboratory diagnosis of SARS-CoV-2: available approaches and 349 limitations Speed versus coverage trade off in targeted No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted Covid-19: Mass testing in Slovakia may have helped cut infections Mass testing for covid-19 in the UK. The Covid-19: Government ramps up"Moonshot"mass testing Clinical evaluation of self-collected saliva by quantitative 363 reverse transcription-PCR (RT-qPCR), Direct RT-qPCR, reverse transcription-364 loop-mediated isothermal amplification, and a rapid antigen test to diagnose 365 COVID-19 Low performance of rapid antigen detection test as frontline 367 testing for COVID-19 diagnosis Head-to-head comparison of four antigen-based rapid detection 370 tests for the diagnosis of SARS-CoV-2 in respiratory samples Protocol for evaluation of rapid diagnostic assays for specific SARS-CoV-373 2 antigens Center of Disease Control and Prevention. Interim Guidelines for Collecting Testing Clinical Specimens for COVID-19 SARS-CoV-2 detection in setting of viral swabs scarcity: 379 Are mrsa swabs and viral swabs equivalent? Influence of Storage Conditions on SARS-CoV-2 Nucleic Acid 382 Detection in Throat Swabs Comparison of seven commercial SARS-CoV-2 rapid Point-384 of-Care Antigen tests. medRxiv Evaluation of three rapid lateral flow antigen detection tests 386 for the diagnosis of SARS-CoV-2 infection Sars-cov-2 (Covid-19) by the 388 numbers The Nucleocapsid Protein of SARS CoV-2: a Target for Vaccine Development Transmissibility of COVID-19 depends on the viral load around 393 onset in adult and symptomatic patients SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected 396 SARS-CoV-2 detection, viral load and infectivity over the 398 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 1 . Heatmap of the LODs on all matrices. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 1 . Heatmap of the LODs on all matrices. Ag-RDTs in direct culture matrix colored green fulfilled WHO criteria. in Amies swab means interference with that matrix, hence LOD is not available. 1 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.